Philippe Halfon
 | This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these messages)
|
Philippe Halfon | |
|---|---|
 | |
| Born | |
| Nationality | French |
| Occupation(s) | Physician, researcher |
Philippe Halfon is the Head of Internal Medicine and Infectious Disease at the Hôpital Européen de Marseille.[1]
Career
[edit]Halfon received a PharmD in 1984 and PhD in 1999 from Aix-Marseille University. He also holds an MD from the University of Medicine of Marseille in 2006[citation needed]. He has previously worked and studied at the associated medical centre at Aix-Marseille University, later working in Infectious Disease in Montreal, Canada.[2]
He was previously appointed Research Director at Aix-Marseille University and an associate professor at Paris Hospital College.[citation needed] He was also a visiting Professor of Medicine at Emory University, United States[citation needed], and Hadassah Medical Centre, Israel.[3][4][5] His research focuses on cancer and virology, including SARS-CoV-2,[6] and he has published on these topics.[7]
Halfon is also the co-founder of biomedical sector companies Alphabio Clinical Laboratories,[8] Panmed Inc.,[2][dead link], and Genoscience Pharma, for which he is also the CEO.[9]
References
[edit]- ^ "Pôle hématologie, infectiologie et médecine interne". L’hôpital Européen. 22 October 2013. Archived from the original on March 2, 2015. Retrieved 18 November 2020.
- ^ a b "LO2A drops outperforms Systane on some measures treating DES patients suffering from Primary Sjogren". 1NewsReport. 23 November 2020. [dead link]
- ^ "Visiting Profesor Hebrew University".
- ^ "HIV carriers can now have healthy children thanks to innovative treatment at Hadassah medical center". Hadassah University Medical Center. Archived from the original on October 26, 2020. Retrieved 17 November 2020.
- ^ "Burden and prevention of Viral Hepatitis in Israel: Lessons learnt and the way forward" (PDF). Viral Hepatitis Prevention Board. Retrieved 17 November 2020.
- ^ "Coronavirus : une étude sur 100 patients marseillais pour "décrypter le dérèglement immunitaire"". La Provence. 16 April 2020. Retrieved 18 November 2020.
- ^ "Philippe Halfon articles". PubMed. Retrieved 18 November 2020.
- ^ "La réponse de Philippe Halfon, MD, PharmD, PhD, Chef de Pole de Médecine Interne et Maladies Infectieuses à l'Hôpital Européen, directeur du laboratoire Alphabio, Marseille Groupe Expert de Médecins de l'AMIF (GEMAMIF)". Association des Médecins Israélites de France. 23 March 2020. Retrieved 18 November 2020.
- ^ "Philippe Halfon, Md, Phd, Pharmd CEO And Founder Genoscience Pharma". lyfebulb. Retrieved 18 November 2020.
| International | |
|---|---|
| Other | |
